Immutep (IMMP) Receivables - Other (2014 - 2021)

Immutep's (IMMP) quarterly Receivables - Other came in at $1.4 million in Q4 2021, down 99.98% on a QoQ basis from $6.0 billion in Q4 2014.

Immutep (IMMP) Receivables - Other (2014 - 2021) Analysis & Trends

Immutep (IMMP) has 2 years of Receivables - Other data on file, last reported at $1.4 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.81 Bn	131.96 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.33 Bn	78.34 Bn	3.93 Bn
3	Argenx Se	65.13 Bn	59.95 Bn	1.37 Bn
4	Moderna	60.47 Bn	55.33 Bn	52.00 Mn
5	BeOne Medicines	42.10 Bn	37.00 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.04 Bn	27.73 Bn	992.69 Mn
7	BioNTech SE	28.48 Bn	10.09 Bn	668.28 Mn
8	Insmed	27.36 Bn	26.20 Bn	358.27 Mn
9	Royalty Pharma	27.23 Bn	26.39 Bn	-
10	Immutep	56.70 Mn	-8.38 Mn	-

Download Data